The evidence that alcohol increases cancer risk is strong and consistent across multiple large studies, and the relationship is considered probably causal. Reducing or stopping drinking entirely is therefore one of the most impactful preventive choices a person can make, comparable to quitting smoking. The effects are most clearly demonstrated for cancer in general; for specific cancer types such as breast cancer, the evidence base is promising but less pronounced.
Alcohol is one of the best-supported diet-related risk factors for cancer. Multiple large studies consistently confirm that alcohol consumption raises the risk of various types of cancer, and that reducing or stopping drinking is therefore a logical and promising strategy for lowering that risk. Experts place alcohol alongside smoking and excess body weight as the three largest avoidable risk factors for cancer.
To put the scale in concrete terms: in the United States in 2014, alcohol was calculated to be responsible for 5.6% of all new cancer diagnoses and 4.0% of all cancer deaths. That amounts to tens of thousands of cases per year that would theoretically have been avoidable. This puts drinking less on a par with quitting smoking as one of the most impactful choices a person can make for their cancer risk.
For breast cancer, specific research has been conducted into stopping alcohol, broken down by the hormone-receptor status of the tumour. That study suggests a reduced risk after stopping alcohol, but the precise size of that effect has not yet been well established. This is a single study; the direction is positive but the evidence is less pronounced than for cancer in general.
In pancreatic cancer, alcohol plays a role by increasing the risk of chronic pancreatic inflammation (pancreatitis), which in turn raises the likelihood of pancreatic cancer. Drinking less can slow the progression of pancreatitis. Nevertheless, quitting smoking is the most effective intervention here; reducing alcohol is complementary but not the key factor.
It has sometimes been suggested that moderate wine drinking is good for the heart. That picture is more nuanced than it appears: observational research does show an association between one to four glasses of wine per week and lower cardiovascular mortality compared with beer or spirits, but studies of this kind are susceptible to confounding by lifestyle, genetics and socioeconomic factors. The true protective effect of alcohol itself is therefore uncertain. For cancer, the implication is clear: there is no safe lower threshold of alcohol consumption at which the risk disappears.
Finally, in people who survived cancer as children, it has been shown that a healthy lifestyle including limited alcohol consumption is associated with a 20 to 30 percent lower chance of health-related mortality in the long term. This is observational research, but the size of the effect is clinically meaningful and the result was independent of other factors.
Based on two strong epidemiological sources (PMID 26267778, 36040006, 29160902) for the relationship between alcohol and cancer risk in general, supplemented by more specific studies on breast cancer (PMID 39633464), pancreatic cancer (PMID 23622135), cardiovascular disease (PMID 35580715) and childhood cancer survivors (PMID 37030315). The causal direction for the increased cancer risk from alcohol is considered probably causal by multiple sources. No meta-analyses were used directly as a source; the strength is based on the consistency of findings across multiple studies.